Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Org Biomol Chem ; 21(45): 9011-9020, 2023 11 22.
Article in English | MEDLINE | ID: mdl-37921761

ABSTRACT

Herein, we report the first solid-phase total synthesis of the natural cyclic peptide anabaenopeptin F and the use of metallaphotoredox catalysis to overcome the key challenges associated with the preparation of the non-proteinogenic amino acid homotyrosine contained in these peptides. Starting from L-homoserine, enantiopure Fmoc-protected homotyrosine was prepared in a straightforward manner by metallaphotoredox catalysis with N-Fmoc-(S)-2-amino-4-bromobutanoic acid and 4-tert-butoxybromobenzene partners. The prepared protected amino acid was used in solid-phase peptide synthesis to achieve the total synthesis of anabaenopeptin F and establish the stereochemistry of the isoleucine residue. Protease inhibition studies with the synthesized anabaenopeptin F showed inhibitory activities against carboxypeptidase B in the low nanomolar range. The high convergency of the synthetic methodologies paves the way for the rapid access to N-Fmoc-protected non-proteinogenic and unnatural amino acids and the total synthesis of complex bioactive peptides containing these amino acids.


Subject(s)
Peptides, Cyclic , Peptides , Peptides/chemistry , Amino Acids/chemistry , Catalysis , Solid-Phase Synthesis Techniques
2.
ACS Omega ; 8(29): 25832-25838, 2023 Jul 25.
Article in English | MEDLINE | ID: mdl-37521620

ABSTRACT

Macrocyclic peptidomimetics have been seriously contributing to our arsenal of drugs to combat diseases. The search for nature's discoveries led us to mortiamides A-D (found in a novel fungus from Northern Canada), which is a family of cyclic peptides that clearly have demonstrated impressive pharmaceutical potential. This prompted us to learn more about their solution-state properties as these are central for binding to target molecules. Here, we secured and isolated mortiamide D, and then acquired high-resolution nuclear magnetic resonance (NMR) data to learn more about its structure and dynamics attributes. Sets of two-dimensional NMR experiments provided atomic-level (through-bond and through-space) data to confirm the primary structure, and NMR-driven molecular dynamics (MD) simulations suggested that more than one predominant three-dimensional (3D) structure exist in solution. Further steps of MD simulations are consistent with the finding that the backbones of mortiamides A-C also have at least two prominent macrocyclic shapes, but the side-chain structures and dynamics differed significantly. Knowledge of these solution properties can be exploited for drug design and discovery.

3.
ACS Med Chem Lett ; 14(2): 217-222, 2023 Feb 09.
Article in English | MEDLINE | ID: mdl-36793432

ABSTRACT

Malaria remains one of the major health problems in the world. In this work, a series of squaramide tethered chloroquine, clindamycin, and mortiamide D hybrids have been synthesized to assess their in vitro antiplasmodial activity against 3D7 (chloroquine-sensitive) and Dd2 strains of Plasmodium falciparum. The most active compound, a simple chloroquine analogue, displayed low nanomolar IC50 value against both strains (3 nM for 3D7 strain and 18 nM for Dd2 strain). Moreover, all molecular hybrids incorporating the hydroxychloroquine scaffold showed the most potent activities, exemplified with a chloroquine dimer, IC50 = 31 nM and 81 nM against 3D7 and Dd2 strains, respectively. These results highlight the first time use of clindamycin and mortiamide D as antimalarial molecular hybrids and establish these valuable hits for future optimization.

4.
Bioorg Med Chem ; 28(23): 115810, 2020 12 01.
Article in English | MEDLINE | ID: mdl-33091849

ABSTRACT

The global increase in microbial resistance is an imminent threat to public health. Effective treatment of infectious diseases now requires new antimicrobial therapies. We report herein the discovery of aromatic-rich piperazines that inhibit biofilm formation by C. albicans. 22 piperazines, including 16 novel ones, were prepared efficiently using a combination of solid- and solution phase synthesis. The most potent compound prevents morphological switching under several hypha-inducing conditions and reduces C. albicans' ability to adhere to epithelial cells. These processes are essential to the development of Candida biofilms, which are associated with its increased resistance to immune defenses and antifungal agents.


Subject(s)
Antifungal Agents/pharmacology , Biofilms/drug effects , Candida albicans/physiology , Piperazines/chemistry , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Cell Line , Cell Survival/drug effects , Humans , Piperazines/chemical synthesis , Piperazines/pharmacology
5.
J Nat Prod ; 83(6): 1778-1783, 2020 06 26.
Article in English | MEDLINE | ID: mdl-32484670

ABSTRACT

Dominicin, a macrocyclic peptide isolated from the marine sponge Eurypon laughlini, has been synthesized for the first time by solid-phase peptide synthesis. The strategy uses oxime resin and takes advantage of the nucleophile susceptibility of the oxime ester bond. The synthesis relies on the preparation of a linear precursor followed by on-resin head-to-tail concomitant cyclization-cleavage. This is the first report of the use of a Boc/OtBu biorthogonal protection strategy on oxime resin to facilitate concomitant N-terminal and side-chain tert-butyl ether deprotection cyclization of unprotected peptides. Also, we report the first antimalarial investigation of dominicin. Interestingly, the natural macrocyclic peptide demonstrates effective low micromolar activity (1.8 µM) against the chloroquine-mefloquine-pyrimethamine-resistant Dd2 strain of Plasmodium falciparum.


Subject(s)
Antimalarials/chemical synthesis , Peptides, Cyclic/chemical synthesis , Porifera/drug effects , Pyrroles/chemical synthesis , Animals , Antimalarials/pharmacology , Cyclization , Drug Resistance , Hemolysis/drug effects , Humans , In Vitro Techniques , Molecular Structure , Peptides/chemical synthesis , Peptides/pharmacology , Peptides, Cyclic/pharmacology , Plasmodium falciparum/drug effects , Pyrroles/pharmacology
6.
Chem Commun (Camb) ; 55(91): 13741-13744, 2019 Nov 12.
Article in English | MEDLINE | ID: mdl-31661093

ABSTRACT

Natural glycopeptides have been shown to possess interesting biological activities. In this work, we have developed a general solid-phase approach to C-terminal glycopeptides. Taking advantage of oxime resin ester bond nucleophile susceptibility, we optimised the nucleophilic cleavage step with glycosylamines and demonstrated the generality and scope of this method. In addition, this reaction has high functional group tolerance and can be used for the preparation of longer C-terminal glycopeptides, demonstrated with the synthesis of a glycododecapeptide in one single step. The results pave the way to access efficiently novel medically relevant compounds.


Subject(s)
Glycopeptides/chemistry , Oximes/chemistry , Antigens, Tumor-Associated, Carbohydrate/chemistry , Biomarkers, Tumor/chemical synthesis , Biomarkers, Tumor/chemistry , Cancer Vaccines/chemical synthesis , Cancer Vaccines/chemistry , Glycopeptides/chemical synthesis , Glycosylation , Humans
7.
Chem Commun (Camb) ; 55(52): 7434-7437, 2019 Jul 04.
Article in English | MEDLINE | ID: mdl-31155628

ABSTRACT

Mortiamides A-D (1-4) are head-to-tail cyclic heptapeptides that were identified from a novel Mortierella sp. isolate obtained from marine sediments from Northern Canada. Herein we report the first total synthesis of mortiamides A-D (1-4) on a solid support by concomitant cyclization/cleavage without any oligomerization side reactions, and overall yields up to 48%. We also report on the antiplasmodial activity of mortiamides A-D (1-4). We show that three out of the four tested mortiamides (A, B and D) have moderate antiplasmodial activity, while mortiamide D (4) exhibits low micromolar activity.


Subject(s)
Antimalarials/chemical synthesis , Peptides, Cyclic/chemical synthesis , Antimalarials/pharmacology , Cyclization , Peptides, Cyclic/pharmacology , Plasmodium falciparum/drug effects , Polymerization
8.
Bioorg Med Chem ; 27(12): 2323-2331, 2019 06 15.
Article in English | MEDLINE | ID: mdl-30528685

ABSTRACT

Microorganisms embedded in a biofilm are significantly more resistant to antimicrobial agents and the defences of the human immune system, than their planktonic counterpart. Consequently, compounds that can inhibit biofilm formation are of great interest for novel therapeutics. In this study, a screening approach was used to identify novel cyclic dipeptides that have anti-biofilm activity against oral pathogens. Five new active compounds were identified that prevent biofilm formation by the cariogenic bacterium Streptococcus mutans and the pathogenic fungus Candida albicans. These compounds also inhibit the adherence of microorganisms to a hydroxylapatite surface. Further investigations were conducted on these compounds to establish the structure-activity relationship, and it was deduced that the common cleft pattern is required for these molecules to act effectively against biofilms.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Bacterial Adhesion/drug effects , Biofilms/drug effects , Dipeptides/pharmacology , Peptides, Cyclic/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Candida albicans/drug effects , Candida albicans/physiology , Dipeptides/chemical synthesis , Dipeptides/chemistry , Microbial Sensitivity Tests , Molecular Structure , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/chemistry , Streptococcus mutans/drug effects , Streptococcus mutans/physiology , Structure-Activity Relationship
9.
Org Biomol Chem ; 16(47): 9117-9123, 2018 12 05.
Article in English | MEDLINE | ID: mdl-30270392

ABSTRACT

Two anabaenopeptins, Schizopeptin 791 and anabaenopeptin NZ825, have similar structural features and have been synthesized via a novel acid-catalyzed head-to-side-chain concomitant cyclization/cleavage reaction on oxime resin. The methodology gave rapid access to the anabaenopeptin scaffold by taking advantage of a combined solid-phase/solution-phase synthetic strategy. Also, as side-products of the synthesis, large C2-symmetric 38-member cyclic peptides ring bearing two endocyclic lysine side-chains were isolated, constituting a novel cyclic peptide scaffold.


Subject(s)
Oximes/chemistry , Peptides, Cyclic/chemical synthesis , Solid-Phase Synthesis Techniques/methods , Catalysis , Cyclization , Peptides, Cyclic/chemistry
10.
Chem Commun (Camb) ; 53(37): 5099-5102, 2017 May 04.
Article in English | MEDLINE | ID: mdl-28422213

ABSTRACT

We describe an efficient epoxidation process leading to chiral epoxyketones using the reusable homo-oligopeptide poly-l-leucine (PLL) in pure water, without any organic co-solvent. A range of substituted epoxyketones can be accessed with good conversions and high enantioselectivities. Based on the experimental results and computational studies, we propose a mechanism that demonstrates the importance of both the α-helical structure and the presence of a hydrophobic groove of the homo-oligopeptide catalyst for reactivity and selectivity.

SELECTION OF CITATIONS
SEARCH DETAIL
...